DH
Therapeutic Areas
Prokarium Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ZH9 | Non-Muscle Invasive Bladder Cancer (NMIBC) | Phase 1 |
| ZH9 + Checkpoint Inhibitors | Muscle-Invasive Bladder Cancer (MIBC) | Discovery/Preclinical |
| IO Prime | Immunotherapy Prime (Indication Agnostic) | Preclinical/IND-enabling |
| Living Cures Platform | Various Cancers (Cargo Delivery) | Discovery |